Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3000 participants
OBSERVATIONAL
2016-09-28
2023-06-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
the investigators analyzed:
* the demographic characteristics of the patient
* the final diagnosis
* the patient's severity and the patient outcome after discharge from MIA
* the justification of the venous and or a urinary catheter
* the duration of the prescription of the device Evaluation on admission of the need to maintain an intravenous or urinary catheter. Adjusting the prescription in terms of duration or withdrawal of the device in order to limit their complications (lymphangitis, superficial thrombophlebitis, bacteremia related to health care, urinary tract infection).
Hypothesis:
Limit the length of stay and reduce the cost of hospitalization.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Bacteraemia Between Peripherally Inserted and Central Inserted Catheters.
NCT02538159
Comparison of Central and Peripheral Venous Catheters
NCT00122707
Infrared for Peripheral Venous Catheterization in the Critically-ill
NCT03932214
Assessment of Ultrasound-guided Inserted Peripheral Intravenous Catheter
NCT01602133
Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival
NCT06107361
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is more than 18 years old.
* Patient who accepts to have his medical records reviewed for research.
* Patient with health insurance
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
jean-olivier ARNAUD
Role: STUDY_DIRECTOR
Assistance Publique Hopitaux De Marseille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assistance Publique Hopitaux de Marseille
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-A00673-48
Identifier Type: OTHER
Identifier Source: secondary_id
2016-15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.